Last reviewed · How we verify

NCT06806098

Cessation Clinical Trial

Active, enrolled NA Last updated 20 November 2025
What this trial tests

NA trial testing Truth Initiative Digital Cessation Program in Tobacco Use Cessation in 2,220 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
5 December 2024
Primary endpoint
30 November 2025
30 November 2025

Quick facts

Lead sponsorTruth Initiative
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment2,220
Start date5 December 2024
Primary completion30 November 2025
Estimated completion30 November 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Truth Initiative

Who can join

18 and older, any sex, with Tobacco Use Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Cessation Clinical Trial will investigate the effectiveness of a digital quit tobacco program in promoting abstinence from tobacco product use compared to usual care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tobacco Use Cessation

Currently open trials in the same condition.

Other Truth Initiative trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06806098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing